Science Daily: Pharmacology News
NOVEMBER 13, 2024
How much land, water, and other resources does our lifestyle require? And how can we adapt this lifestyle to stay within the limits of what the Earth can give? A new article tackles these questions.
Drugs.com
NOVEMBER 13, 2024
WEDNESDAY, Nov. 13, 2024 -- The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb drinking for people battling alcohol use disorder, helping them to avoid crises that require hospitalization, new research shows. Numerous studies had.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
NOVEMBER 13, 2024
A 'one of a kind' fossil discovery could transform our understanding of how the unique brains and intelligence of modern birds evolved, one of the most enduring mysteries of vertebrate evolution.
BioPharma Drive: Drug Pricing
NOVEMBER 13, 2024
Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit Therapeutics’ ivonescimab over Keytruda.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Science Daily: Pharmacology News
NOVEMBER 13, 2024
Could social bonds be the key to human big brains? A study of the fossil teeth of early Homo from Georgia dating back 1.77 million years reveals a prolonged childhood despite a small brain and an adulthood comparable to that of the great apes. This discovery suggests that an extended childhood, combined with cultural transmission in three-generation social groups, may have triggered the evolution of a large brain like that of modern humans, rather than the reverse.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Science Daily: Pharmacology News
NOVEMBER 13, 2024
A collection of perforated pebbles from an archaeological site in Israel may be spindle whorls, representing a key milestone in the development of rotational tools including wheels, according to a new study.
Drugs.com
NOVEMBER 13, 2024
WEDNESDAY, Nov. 13, 2024 -- People are at higher risk of schizophrenia if they indulge in psychedelic drugs, a new study warns.Patients who land in the ER following hallucinogen use have a 21-fold higher risk of developing schizophrenia compared to.
Science Daily: Pharmacology News
NOVEMBER 13, 2024
Scientists using observations from NASA's Neil Gehrels Swift Observatory have discovered, for the first time, the signal from a pair of monster black holes disrupting a cloud of gas in the center of a galaxy.
Drugs.com
NOVEMBER 13, 2024
WEDNESDAY, Nov. 13, 2024 -- A newly developed AI program can help doctors detect and potentially remove brain cancer that might otherwise be missed during surgery, a new study demonstrates.The AI, called FastGlioma, calculated how much residual.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Drive: Drug Pricing
NOVEMBER 13, 2024
An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis struck drug discovery deals.
Drugs.com
NOVEMBER 13, 2024
WEDNESDAY, Nov. 13, 2024 -- Most parents haven’t considered the potential risk of an unlocked, poorly stored firearm in a house their child is visiting, a new study shows.More than 60% of Illinois parents have never asked another parent about an u.
BioPharma Drive: Drug Pricing
NOVEMBER 13, 2024
The California biotech has drawn partnerships with Eli Lilly and J&J on the promise of its approach to rebalancing the immune system.
Drugs.com
NOVEMBER 13, 2024
WEDNESDAY, Nov. 13, 2024 -- Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns.By 2018, federal data showed that 42% of adults had some form of fatty liver disease -- higher.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Science Daily: Pharmacology News
NOVEMBER 13, 2024
Glaciers that are within three miles of a volcano move nearly 50% quicker than average, a new study has found, which could help create early warning of future eruptions.
Drugs.com
NOVEMBER 13, 2024
WEDNESDAY, Nov. 13, 2024 -- Amid an ongoing outbreak of bird flu in American dairy herds and poultry flocks, Canadian officials have announced that a teen in British Columbia has been hospitalized in critical condition with what is believed to be.
BioPharma Drive: Drug Pricing
NOVEMBER 13, 2024
With promising Phase 1 results in hand, Metsera hopes to develop a longer-lasting GLP-1 injection along with other types of obesity treatments.
Drugs.com
NOVEMBER 13, 2024
WEDNESDAY, Nov. 13, 2024 -- Therapy provided via telehealth can reduce a person’s risk of suicide, a new study reports.Cognitive behavior therapy reduces suicide attempts and suicidal thoughts even if delivered for a short time via telehealth, a.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
BioPharma Drive: Drug Pricing
NOVEMBER 13, 2024
The genetic testing firm will also close its drug development arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the long-term success of our core consumer business.
Drugs.com
NOVEMBER 13, 2024
WEDNESDAY, Nov. 13, 2024 -- High blood pressure is a rare health issue among teens, but U.S. case numbers are creeping upwards.Now, research published recently in the Journal of the American Heart Association, shows that healthy sleep can help keep.
BioPharma Drive: Drug Pricing
NOVEMBER 13, 2024
The pharma is trying to win court backing to pay hospitals rebates for two drugs in the 340B drug discount program, instead of offering upfront discounts.
Drugs.com
NOVEMBER 13, 2024
WEDNESDAY, Nov. 13, 2024 -- Bottoms up: The type of alcohol you prefer may say something about your lifestyle, new research reveals.Beer drinkers are more likely to have an unhealthy lifestyle than folks who prefer wine or liquor, scientists.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Fierce BioTech
NOVEMBER 13, 2024
| Discover how minimal residual disease (MRD) assessment is accelerating multiple myeloma drug development through FDA's latest guidance.
Alta Sciences
NOVEMBER 13, 2024
Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services pmjackson Wed, 11/13/2024 - 14:50 Greater Montréal, Québec, 11/13, 2024 — Altasciences , a trusted drug development research partner for over 30 years, continues its commitment to providing world-class bioanalytical services. This core business supports both preclinical and clinical studies conducted at Altasciences’ facilities, while also offering an extensive standalone solution to meet the div
Crown Bioscience
NOVEMBER 13, 2024
Following on from OX40 , our TNF superfamily posts continue with 4-1BB, another important target in T cell co-stimulation.
Fierce BioTech
NOVEMBER 13, 2024
Building a “Best Practice” R&D Organization in Biopharma We interviewed 14 R&D biopharma leaders on the critical success factors for building a Best Practice R&D organization. This report shares what we learned. lbarrick Wed, 11/13/2024 - 14:04 We interviewed 14 R&D biopharma leaders on the critical success factors for building a Best Practice R&D organization.
Alta Sciences
NOVEMBER 13, 2024
BioBuzz: Part One—Exploring Philadelphia's CDMOs aasimakopoulos Wed, 11/13/2024 - 14:40 Category News Tags Manufacturing and Analytical Services Weight 1
Expert insights. Personalized for you.
318 
Let's personalize your content